Methylation of 10 miRNA genes in clear cell renal cell carcinoma and their diagnostic value
- Authors: Loginov V.I.1, Beresneva E.V.2, Kazubskaya T.R.3, Braga E.A.1, Karpukhin A.V.4
-
Affiliations:
- Research Center for Medical Genetics Institute of General Pathology and Pathophysiology
- State Research Institute for Genetics and Selection of Industrial Microorganisms
- N. N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia
- Research Center for Medical Genetics
- Issue: Vol 13, No 3 (2017)
- Pages: 27-33
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER
- Published: 30.09.2017
- URL: https://oncourology.abvpress.ru/oncur/article/view/696
- DOI: https://doi.org/10.17650/1726-9776-2017-13-3-27-33
- ID: 696
Cite item
Abstract
Introduction. Clear cell renal cell carcinoma (ccRCC) is characterized by the high (30–40 % of cases) frequency of lethal outcomes which at metastasis reaches 90 %. Lack of efficient diagnostics at early stages of a disease indicates the need of searching on new ccRCC markers.
Objective: for definition of methylation role of some tumor suppressor microRNA (miRNA) genes in ccRCC pathogenesis and progression and marker identification for ccRCC diagnostics and metastasis predictions.
Materials and methods. The alterations of methylation status of 10 miRNA genes were determined by methylation specific polymerase chain reaction in tumor DNA samples and matched histologically unchanged tissues from 70 patients with ccRCC, as well as in DNA samples of kidney tissues from 19 post-mortal individuals without cancer history. Methylation of MIR MIR-107, -130b and -148a genes in ccRCC was studied for the first time.
Results. It was shown that 8 miRNA genes (MIR-9-1/3, -34b/c, -124a-1/2/3, -129-2, -130b) were methylated in ccRCC tumors with significantly higher frequency than in the matched histologically unchanged kidney tissues. It was established the association of methylation of 4 miRNA genes (MIR-107, -124a-3, -129-2, -130b) with ccRCC progression (stage, tumor size, differentiation grade), including metastasis in the lymph nodes or distant organs, revealed for MIR-107 and -129-2. The association of MIR-107 and -130b methylation with progression of ccRCC is shown for the first time. Potential marker systems are made for ccRCC diagnostics using tumor biopsy; according to the ROC analysis, systems from 4 and 5 genes (MIR-9-1, -4b/c, -124a-3, -129-2/with addition of MIR-130b) are characterized by high clinical sensitivity of 90 % and specificity of 94 % (area under ROC curve 0.93 and 0.94).
Conclusion. The received results will form the basis of noninvasive ccRCC diagnostics further development. To conclude, it is shown the association of methylation of 9 miRNA genes with ccRCC pathogenesis and progression and its potential diagnostic value.
About the authors
V. I. Loginov
Research Center for Medical GeneticsInstitute of General Pathology and Pathophysiology
1 Moskvorech’e St., Moscow 115478, Russia
8 Baltiyskaya St., Moscow 125315, Russia
Russian FederationE. V. Beresneva
State Research Institute for Genetics and Selection of Industrial Microorganisms1 Pervyy Dorozhnyy Proezd, 117545 Moscow, Russia
T. R. Kazubskaya
N. N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia23 Kashirskoe Shosse, Moscow 115478, Russia
E. A. Braga
Research Center for Medical GeneticsInstitute of General Pathology and Pathophysiology
1 Moskvorech’e St., Moscow 115478, Russia
8 Baltiyskaya St., Moscow 125315, Russia
A. V. Karpukhin
Research Center for Medical Genetics
Author for correspondence.
Email: karpukhin@med-gen.ru
1 Moskvorech’e St., Moscow 115478, Russia Russian Federation
References
Supplementary files

